Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (211-220 of 358) with videos related to

Pageof 36
Sort By:
AIDS and Behavior|January 4, 2022
Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIVMattia Trunfio, Davide De Francesco, Daniela Vai, et al.
British Journal of Clinical Pharmacology|April 23, 2021
Medication burden and clustering in people living with HIV undergoing therapeutic drug monitoringAndrea Calcagno, Amedeo de Nicolò, Costanza Pizzi, et al.
Vaccine|January 25, 2014
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity studyMaria Luisa Iaria, Simona Fiorentini, Emanuele Focà, et al.
Plos One|August 5, 2021
Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what mattersStefano Cosma, Andrea Roberto Carosso, Jessica Cusato, et al.
AIDS (London, England)|October 9, 2002
Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamicsMarta Boffito, Isabella Arnaudo, Riccardo Raiteri, et al.
AIDS and Behavior|July 30, 2024
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational StudyMattia Trunfio, Elisa Vuaran, Daniela Vai, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2012
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriersLaurenzia Ferraris, Ottavia Viganò, Anna Peri, et al.
The Journal of Infectious Diseases|March 1, 2020
Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot StudyCecilia Costa, Silvia Scabini, Arvind Kaimal, et al.
International Journal of Antimicrobial Agents|March 20, 2024
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIVJessica Cusato, Alessandra Manca, Alice Palermiti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 19, 2011
Ceftriaxone bone penetration in patients with septic non-union of the tibiaSilvia Garazzino, Alessandro Aprato, Lorena Baietto, et al.
Pageof 36

Showing results (211-220 of 358) with videos related to

Sort By:
Pageof 36
AIDS and Behavior|January 4, 2022
Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIVMattia Trunfio, Davide De Francesco, Daniela Vai, et al.
British Journal of Clinical Pharmacology|April 23, 2021
Medication burden and clustering in people living with HIV undergoing therapeutic drug monitoringAndrea Calcagno, Amedeo de Nicolò, Costanza Pizzi, et al.
Vaccine|January 25, 2014
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity studyMaria Luisa Iaria, Simona Fiorentini, Emanuele Focà, et al.
Plos One|August 5, 2021
Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what mattersStefano Cosma, Andrea Roberto Carosso, Jessica Cusato, et al.
AIDS (London, England)|October 9, 2002
Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamicsMarta Boffito, Isabella Arnaudo, Riccardo Raiteri, et al.
AIDS and Behavior|July 30, 2024
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational StudyMattia Trunfio, Elisa Vuaran, Daniela Vai, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2012
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriersLaurenzia Ferraris, Ottavia Viganò, Anna Peri, et al.
The Journal of Infectious Diseases|March 1, 2020
Calcaneal Quantitative Ultrasonography and Urinary Retinol-Binding Protein in Antiretroviral-Treated Patients With Human Immunodeficiency Virus in Uganda: A Pilot StudyCecilia Costa, Silvia Scabini, Arvind Kaimal, et al.
International Journal of Antimicrobial Agents|March 20, 2024
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIVJessica Cusato, Alessandra Manca, Alice Palermiti, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 19, 2011
Ceftriaxone bone penetration in patients with septic non-union of the tibiaSilvia Garazzino, Alessandro Aprato, Lorena Baietto, et al.
Pageof 36